Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.4.21.64 (
proteinase K
)
4,071
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Transcription factor (TF) IIA performs two important regulatory functions during RNA polymerase II transcription: it is required for efficient binding of TFIID to a core promoter and it mediates the effects of upstream activators, both through direct interaction with the TATA box binding protein (TBP). To begin studying how
TFIIA
mediates these effects, we used a highly sensitive protease footprinting methodology to identify surfaces of human
TFIIA
participating in
TFIIA
x TBP x TATA ternary complex formation. Chymotrypsin and
proteinase K
cleavage patterns of
TFIIA
bearing a 32P-end-labeled gamma subunit revealed that amino acids 59-73 were protected from cleavage both in the context of an immobilized ternary complex and in a binary complex with TBP alone. In contrast, amino acids 341-367 in the beta portion of a 32P-labeled alpha-beta subunit were protected in the ternary but not in the binary complex, implying that those residues interact with promoter DNA. The regions of human
TFIIA
identified by protease footprinting are homologous to and encompass the yeast
TFIIA
residues that contact TBP and DNA in the recently solved crystal structure of the yeast ternary complex. The conservation of the regions and residues mediating complex formation implies that yeast and human
TFIIA
employ the same mechanism to stabilize the binding of TFIID to a core promoter.
...
PMID:Protease footprinting analysis of ternary complex formation by human TFIIA. 899 19